North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

4D Molecular Therapeutics Inc. 1.29% $218.19M ...

ContentsUS exits Paris Agreement againAre biofuels subsidies at risk?Buffer factors: Republicans could ringfence biofuelsWhy ...

A Winnipeg-based biotechnology company says it's open to any financial help it can get from Ottawa as the U.S. continues to ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $446.4 million specializing in mRNA therapeutics and vaccines, stands at a ...

Rein Therapeutics (NASDAQ:RNTX) received a Buy rating from Rodman & Renshaw, with a newly established price target of $8.00. The firm began its coverage of the biotech company, highlighting its focus ...

ProductLife Group (PLG), a global provider of regulatory, scientific, compliance, and digital transformation consulting ...

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to ...

Learn more about whether Standex International Corporation or Symbotic Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Bio-Rad Laboratories, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor ...

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...